![Albert Fenwick Fleury](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Albert Fenwick Fleury
Presidente presso
Cordex Systems, Inc.
Profilo
Albert Fenwick Fleury currently works at QIAGEN North American Holdings, Inc., as Director-Corporate Finance & Investor Relations from 2007 and Cordex Systems, Inc., as President & Chief Operating Officer.
Mr. Fleury also formerly worked at Digene Corp., as Director-Investor Relations from 2001 to 2007.
Posizioni attive di Albert Fenwick Fleury
| Società | Posizione | Inizio |
|---|---|---|
QIAGEN North American Holdings, Inc.
 QIAGEN North American Holdings, Inc. Pharmaceuticals: MajorHealth Technology Provides biotechnology services | Contatto Relazioni con gli Investitori | - |
Cordex Systems, Inc.
 Cordex Systems, Inc. Medical SpecialtiesHealth Technology Manufactures cardiovascular diagnostic device | Presidente | - |
Precedenti posizioni note di Albert Fenwick Fleury
| Società | Posizione | Fine |
|---|---|---|
Digene Corp.
 Digene Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and markets DNA and RNA tests | Corporate Officer/Principal | 01/06/2007 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
12
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Digene Corp.
Digene Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and markets DNA and RNA tests | Electronic Technology |
QIAGEN North American Holdings, Inc.
QIAGEN North American Holdings, Inc. Pharmaceuticals: MajorHealth Technology Provides biotechnology services | Health Technology |
Cordex Systems, Inc.
Cordex Systems, Inc. Medical SpecialtiesHealth Technology Manufactures cardiovascular diagnostic device | Health Technology |
